CN104673894B - 一种分子标记检测物在制备检测肝癌的试剂盒中的用途 - Google Patents
一种分子标记检测物在制备检测肝癌的试剂盒中的用途 Download PDFInfo
- Publication number
- CN104673894B CN104673894B CN201510024578.5A CN201510024578A CN104673894B CN 104673894 B CN104673894 B CN 104673894B CN 201510024578 A CN201510024578 A CN 201510024578A CN 104673894 B CN104673894 B CN 104673894B
- Authority
- CN
- China
- Prior art keywords
- detection
- liver cancer
- cyclin
- primer
- mir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
年龄 | 样本数 | 肿瘤严重程度 | 样本数 |
≤50 | 72 | G1 | 31 |
>50 | 58 | G2 | 76 |
G3 | 23 | ||
性别 | 样本数 | ||
男 | 96 | 肿瘤生长特点 | 样本数 |
女 | 34 | 小梁型 | 101 |
非小梁型 | 29 | ||
血清甲胎蛋白 | 样本数 | ||
阳性 | 72 | 肝硬化 | |
阴性 | 58 | 是 | 86 |
否 | 44 | ||
肿瘤分期 | 样本数 | ||
T1 | 23 | 并发肝病 | 样本数 |
T2 | 40 | 酒精肝 | 25 |
T3 | 52 | HBV感染 | 49 |
T4 | 15 | HCV感染 | 35 |
未知肝病 | 21 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510024578.5A CN104673894B (zh) | 2015-01-16 | 2015-01-16 | 一种分子标记检测物在制备检测肝癌的试剂盒中的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510024578.5A CN104673894B (zh) | 2015-01-16 | 2015-01-16 | 一种分子标记检测物在制备检测肝癌的试剂盒中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104673894A CN104673894A (zh) | 2015-06-03 |
CN104673894B true CN104673894B (zh) | 2018-03-02 |
Family
ID=53309480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510024578.5A Expired - Fee Related CN104673894B (zh) | 2015-01-16 | 2015-01-16 | 一种分子标记检测物在制备检测肝癌的试剂盒中的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104673894B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106405104B (zh) * | 2016-08-31 | 2019-01-08 | 鲁凤民 | 一种新的肝硬化或肝纤维化标志物 |
CN106383231B (zh) * | 2016-09-02 | 2020-03-17 | 四川大学 | 一种诊断肝癌的标记物组合及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102586412B (zh) * | 2011-01-18 | 2015-05-20 | 上海市第一人民医院 | 一种MicroRNA特异表达谱及其应用 |
CN102298053B (zh) * | 2011-05-20 | 2014-01-29 | 中山大学肿瘤防治中心 | 原发性肝细胞肝癌术后复发风险评估的组合抗体试剂盒 |
-
2015
- 2015-01-16 CN CN201510024578.5A patent/CN104673894B/zh not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
CyclinD1 在肝细胞癌中的表达及与肝细胞癌患者预后的关系;李启炯等;《中华临床医师杂志》;20120115;355 * |
Systematic validation of predicted microRNAs for cyclin D1;Qiong Jiang, Ming-Guang Feng and Yin-Yuan Mo;《BMC Cancer》;20090618;194 * |
肝癌肝移植术后肿瘤复发相关microRNAs的筛选验证及分子机制研究;韩中博;《道客巴巴》;20140320;13-84 * |
Also Published As
Publication number | Publication date |
---|---|
CN104673894A (zh) | 2015-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kanaan et al. | Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease‐associated colorectal cancer | |
Silakit et al. | Circulating mi R‐192 in liver fluke‐associated cholangiocarcinoma patients: a prospective prognostic indicator | |
Dang et al. | Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells | |
Cai et al. | Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma | |
Liu et al. | Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study | |
El-Garem et al. | Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma | |
US20200157631A1 (en) | CIRCULATING miRNAs AS MARKERS FOR BREAST CANCER | |
Wang et al. | Screening miRNAs for early diagnosis of colorectal cancer by small RNA deep sequencing and evaluation in a Chinese patient population | |
Liang et al. | Expression and significance of microRNA-183 in hepatocellular carcinoma | |
De Palma et al. | The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma | |
JP2011501964A (ja) | 扁平上皮細胞肺癌の予後予測プロセス | |
Cai et al. | Expression of miR-221 in colon cancer correlates with prognosis | |
US11603566B2 (en) | Methods for diagnosing and treating esophageal cancer | |
KR101532210B1 (ko) | 플라즈마 마크로알엔에이로 구성된 간암 진단 마커 및 간암 진단의 새로운 방법 | |
Shehab-Eldeen et al. | Diagnostic performance of microRNA-122 and microRNA-224 in hepatitis C virus-induced hepatocellular carcinoma (HCC) | |
CN103725779A (zh) | 一种非小细胞肺癌早期诊断血清/血浆miRNA标志物及其应用 | |
CN105463070A (zh) | Uca1基因在制备诊断结直肠癌产品中的应用 | |
CN104673894B (zh) | 一种分子标记检测物在制备检测肝癌的试剂盒中的用途 | |
EP2870259B1 (en) | A mirna oncologic biomarker of breast cancer | |
Jiang et al. | Increased long non-coding RNA ARAP1-AS1 expression and its prognostic significance in human gastric cancer: a preliminary study. | |
Sisic et al. | Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer | |
Wu et al. | Circ_0000064 adsorption of microRNA-143 promotes malignant progression of hepatocellular carcinoma. | |
Meng et al. | MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer | |
CN103589786B (zh) | 检测RRM1 mRNA相对表达量的方法、试剂盒及引物和探针 | |
CN103173449A (zh) | 与食管癌术后早期复发和预后相关的miRNA标志物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Yanqiong Inventor after: Guo Xiaodong Inventor after: Lin Na Inventor after: Yang Mei Inventor before: Zhang Yanqiong Inventor before: Guo Xiaodong Inventor before: Zhao Jingmin Inventor before: Lin Na Inventor before: Yang Mei |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180302 Termination date: 20220116 |
|
CF01 | Termination of patent right due to non-payment of annual fee |